Prednisolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race
暂无分享,去创建一个
[1] J. Johnson,et al. Influence of race or ethnicity on pharmacokinetics of drugs. , 1997, Journal of pharmaceutical sciences.
[2] H. Moldofsky,et al. Diurnal sleep/wake‐related immune functions during the menstrual cycle of healthy young women , 1995, Journal of sleep research.
[3] J. Alexander,et al. Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine era. , 1997, Clinical transplantation.
[4] P. Meffin,et al. Alterations in prednisolone disposition as a result of time of administration, gender and dose. , 1984, British journal of clinical pharmacology.
[5] A. Fauci,et al. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. , 1976, Annals of internal medicine.
[6] S. Yong,et al. Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes. , 1984, Clinical immunology and immunopathology.
[7] W. Jusko,et al. Prednisolone binding to albumin and transcortin in the presence of cortisol. , 1982, Biochemical pharmacology.
[8] J. P. Singh,et al. Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients. , 1995, Transplantation.
[9] R. Freedman,et al. Sex Differences in Peripheral Vascular Adrenergic Receptors , 1987, Circulation research.
[10] E. Schuetz,et al. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. , 1995, The Journal of pharmacology and experimental therapeutics.
[11] D. Dubey,et al. Increased PGE2 from human monocytes isolated in the luteal phase of the menstrual cycle. Implications for immunity? , 1994, Prostaglandins.
[12] F. G. McDonald,et al. Variation in natural killer activity in peripheral blood during the menstrual cycle. , 1985, British medical journal.
[13] J L Brazier,et al. Pharmacokinetics of caffeine during and after pregnancy. , 1983, Developmental pharmacology and therapeutics.
[14] J. Witte,et al. CYP3A activity in African American and European American men: Population differences and functional effect of the CYP3A4*1B 5′‐promoter region polymorphism , 2000, Clinical pharmacology and therapeutics.
[15] J. Carmody,et al. Experimental Pain in Healthy Human Subjects: Gender Differences in Nociception and in Response to Ibuprofen , 1998, Anesthesia and analgesia.
[16] W J Jusko,et al. Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena. , 1998, Journal of pharmaceutical sciences.
[17] W. Jusko,et al. Prednisolone disposition and protein binding in oral contraceptive users. , 1983, The Journal of clinical endocrinology and metabolism.
[18] H. Saitoh,et al. Defferent Absorption Behaviors among Steroid Hormones Due to Possible Interaction with P-Glycoprotein in the Rat Small Intestine , 1999 .
[19] M. Lehmann,et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. , 1993, JAMA.
[20] J. Schwartz,et al. Aging of women alters S‐verapamil pharmacokinetics and pharmacodynamics , 1994, Clinical pharmacology and therapeutics.
[21] W. Jusko,et al. Pharmacoimmunodynamic interactions of interleukin‐10 and prednisone in healthy volunteers , 1999, Clinical pharmacology and therapeutics.
[22] W. Jusko,et al. Gender‐based effects on methylprednisolone pharmacokinetics and pharmacodynamics , 1993, Clinical pharmacology and therapeutics.
[23] W J Jusko,et al. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects , 1989, Clinical pharmacology and therapeutics.
[24] R. Horst,et al. Regulation of L‐selectin and CD18 on bovine neutrophils by glucocorticoids: effects of cortisol and dexamethasone , 1995, Journal of leukocyte biology.
[25] M. Polan,et al. Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1. , 1990, The Journal of clinical endocrinology and metabolism.
[26] E. Bloemena,et al. The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo , 1990, Clinical and experimental immunology.
[27] W. Jusko,et al. Corticosteroid analysis in biological fluids by high-performance liquid chromatography. , 1979, Journal of chromatography.
[28] J. Neylan. Immunosuppressive Therapy In High-risk Transplant Patients: Dose-dependent Efficacy Of Mycophenolate Mofetil In African-american Renal Allograft Recipients1 , 1997 .
[29] W. Jusko,et al. Pharmacokinetic and Adrenal Interactions of IL‐10 and Prednisone in Healthy Volunteers , 1999, Journal of clinical pharmacology.
[30] A. Kashuba,et al. Physiological Changes During the Menstrual Cycle and Their Effects on the Pharmacokinetics and Pharmacodynamics of Drugs , 1998, Clinical pharmacokinetics.
[31] T. Miyawaki,et al. Circadian changes of T lymphocyte subsets in human peripheral blood. , 1984, Clinical and experimental immunology.
[32] J. Neylan. Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. , 1997, Transplantation.
[33] J. Goust,et al. Cyclic variations in white cell subpopulations in the human menstrual cycle: correlations with progesterone and estradiol. , 1979, Clinical immunology and immunopathology.
[34] F. Frey,et al. Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism. , 1983, The Journal of laboratory and clinical medicine.
[35] S. Ansar Ahmed,et al. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. , 1985, The American journal of pathology.
[36] N. Pyszczynski,et al. Fifteen years of operation of a high-performance liquid chromatographic assay for prednisolone, cortisol and prednisone in plasma. , 1994, Journal of chromatography. B, Biomedical applications.
[37] Honghao Zhou,et al. Ethnic Differences in Drug Disposition and Responsiveness , 1991, Clinical pharmacokinetics.
[38] W. Jusko,et al. ALGORITHM FOR APPLICATION OF FOURIER ANALYSIS FOR BIORHYTHMIC BASELINES OF PHARMACODYNAMIC INDIRECT RESPONSE MODELS , 2000, Chronobiology international.
[39] R. Venuto,et al. Racial Differences in the Pharmacokinetics of Methylprednisolone in Black and White Renal Transplant Recipients , 1993, Pharmacotherapy.